Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA

(Synonyms: ACTH (1-39) (mouse, rat) TFA) Copy Product Info
🥰Excellent

Synonyms: ACTH (1-39) (mouse, rat) TFA

Catalog No. T10251 Copy Product Info
🥰Excellent
Adrenocorticotropic Hormone (ACTH) (1-39), rat (TFA), is a potent agonist of the melanocortin 2 receptor (MC2).
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$197InquiryInquiry
5 mg$797InquiryInquiry
10 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Adrenocorticotropic Hormone (ACTH) (1-39), rat (TFA), is a potent agonist of the melanocortin 2 receptor (MC2).
In vitro
ACTH 1-39, within the concentration range of 100-400 nM, exhibits no cytotoxic effects on neurons and notably safeguards them against excitotoxic neuronal death triggered by various agents such as glutamate (100 μM), NMDA (1 mM), AMPA (50 μM), and kainate (25 μM), with the 400 nM concentration ensuring substantial protection across all instances. Similarly, ACTH at both 200 and 400 nM concentrations effectively shields neurons from the detrimental effects of quinolinic acid (25 μM). Furthermore, ACTH mitigates cell mortality caused by 2 μM H2O2, which leads to the production of reactive oxygen species (ROS), with protection being notably greater at 400 nM than at 200 nM. Additionally, ACTH offers limited defense against the immediate release of nitric oxide (NO) by NOC-12, albeit it does not counter the slow release by NOC-18. Moreover, at concentrations of 200 or 400 nM, ACTH affords neuronal protection from the cytotoxic impacts of staurosporine (10-20 nM), a well-established inducer of apoptosis, consequently reducing cell death from 80% to 55% [1].
In vivo
Intracerebroventricular (icv) administration of ACTH notably lowers total food consumption over the study period in comparison to the saline/IgG control group. Introducing ACTH antibody (Ab) into the paraventricular nucleus (PVN) negates ACTH's appetite-suppressing effect. Conversely, ACTH's icv infusion markedly reduces food intake in rats also receiving α-MSH Ab in the PVN, aligning their consumption levels with rats given ACTH icv and IgG in the PVN. Moreover, injecting either ACTH Ab or α-MSH Ab into the PVN significantly boosts food intake relative to animals treated with IgG alone [2].
SynonymsACTH (1-39) (mouse, rat) TFA
Animal Research
Male Wistar rats (weight range 225-250 g at purchase) are used throughout the study. Animals receive a PVN application of ACTH Ab (2 μg/rat) or IgG (2 μg/rat); administration of either ACTH (1 nM/rat) or saline icv is performed 5 min later [2].
Chemical Properties
Molecular Weight4696.18
FormulaC212H316F3N57O59S
Relative Density.no data available
SequenceSer-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe
Sequence ShortSYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF
Storage & Solubility Information
StorageKeep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Keywords

Related Tags: Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA chemical structure | Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA in vivo | Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA in vitro | Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA formula | Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA molecular weight